cd5 Search Results


93
Miltenyi Biotec anti human cd5 rea782 pe

Anti Human Cd5 Rea782 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/CD5+Antibody%2C+anti-human%2C+REAfinity/pmc08809252-102-0-5
Average 93 stars, based on 1 article reviews
anti human cd5 rea782 pe - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc cell signal 1997

Cell Signal 1997, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/CD5+Antibody/pm18690040-475-0-0
Average 94 stars, based on 1 article reviews
cell signal 1997 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

93
Bio-Rad dog cd5

Dog Cd5, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/Rat+anti+Dog+CD5/pmc05357040-92-34-38
Average 93 stars, based on 1 article reviews
dog cd5 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

92
Proteintech cd5
Figure 2. Dynamic alterations of lung TJ and AJ, HUVEC permeability, and neutrophils after LPS administration in vivo and in vitro. E-cadherin (A, A9), VE-cadherin (B, B9), occludin (C, C0), CD11b (E, E9), and MPO (F, F9) staining and quantification of relative intensity or positive cells in 1 alveoli at 1, 3, 5, and 7 d after administration of LPS (15 mg/kg) or saline; and CD3, <t>CD5,</t> CD19, and CD45 staining (G) at 3 d after LPS treatment are shown. D) Double-labeling images are shown of occludin (red) with E-cadherin or VE-cadherin (green) and superimposition with DAPI (blue). H) Percentage of CD11b-, MPO-, CD3-, CD5-, CD19-, and CD45-positive cells in 1 alveoli. I) Levels of IL-6, IL-8, and TNF-a and MPO activity in the supernatants of human neutrophils at 1, 3, 5, 7, and 9 h after LPS (10 mg/ml) treatment are shown. J) HUVEC monolayer permeability, as reflected by FITC-albumin fluorescence intensity, was analyzed at 1, 3, 5, 7, and 9 h after treatment of LPS alone or LPS + neutrophil supernatants (LPS + S). Values are expressed as the means 6 SE; n = 3 (I, J); n = 10–13 alveoli from 3 mice (A2C9, E9,F9, H). Scale bars: 5 mm (D); 30 mm (A–C. E–G). N.S., no significant difference. **P , 0.01 compared with the control group, ##P , 0.01 compared with LPS group at 1 h.
Cd5, supplied by Proteintech, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/CD5+Antibody/10__1096_slash_fj__201701506rr-43-1-8
Average 92 stars, based on 1 article reviews
cd5 - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

90
R&D Systems mouse monoclonal anti human cd5 antibody
Figure 2. Dynamic alterations of lung TJ and AJ, HUVEC permeability, and neutrophils after LPS administration in vivo and in vitro. E-cadherin (A, A9), VE-cadherin (B, B9), occludin (C, C0), CD11b (E, E9), and MPO (F, F9) staining and quantification of relative intensity or positive cells in 1 alveoli at 1, 3, 5, and 7 d after administration of LPS (15 mg/kg) or saline; and CD3, <t>CD5,</t> CD19, and CD45 staining (G) at 3 d after LPS treatment are shown. D) Double-labeling images are shown of occludin (red) with E-cadherin or VE-cadherin (green) and superimposition with DAPI (blue). H) Percentage of CD11b-, MPO-, CD3-, CD5-, CD19-, and CD45-positive cells in 1 alveoli. I) Levels of IL-6, IL-8, and TNF-a and MPO activity in the supernatants of human neutrophils at 1, 3, 5, 7, and 9 h after LPS (10 mg/ml) treatment are shown. J) HUVEC monolayer permeability, as reflected by FITC-albumin fluorescence intensity, was analyzed at 1, 3, 5, 7, and 9 h after treatment of LPS alone or LPS + neutrophil supernatants (LPS + S). Values are expressed as the means 6 SE; n = 3 (I, J); n = 10–13 alveoli from 3 mice (A2C9, E9,F9, H). Scale bars: 5 mm (D); 30 mm (A–C. E–G). N.S., no significant difference. **P , 0.01 compared with the control group, ##P , 0.01 compared with LPS group at 1 h.
Mouse Monoclonal Anti Human Cd5 Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/Human+CD5+Antibody/pmc02361902-13-5-13
Average 90 stars, based on 1 article reviews
mouse monoclonal anti human cd5 antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

93
Miltenyi Biotec anti mouse
Figure 2. Dynamic alterations of lung TJ and AJ, HUVEC permeability, and neutrophils after LPS administration in vivo and in vitro. E-cadherin (A, A9), VE-cadherin (B, B9), occludin (C, C0), CD11b (E, E9), and MPO (F, F9) staining and quantification of relative intensity or positive cells in 1 alveoli at 1, 3, 5, and 7 d after administration of LPS (15 mg/kg) or saline; and CD3, <t>CD5,</t> CD19, and CD45 staining (G) at 3 d after LPS treatment are shown. D) Double-labeling images are shown of occludin (red) with E-cadherin or VE-cadherin (green) and superimposition with DAPI (blue). H) Percentage of CD11b-, MPO-, CD3-, CD5-, CD19-, and CD45-positive cells in 1 alveoli. I) Levels of IL-6, IL-8, and TNF-a and MPO activity in the supernatants of human neutrophils at 1, 3, 5, 7, and 9 h after LPS (10 mg/ml) treatment are shown. J) HUVEC monolayer permeability, as reflected by FITC-albumin fluorescence intensity, was analyzed at 1, 3, 5, 7, and 9 h after treatment of LPS alone or LPS + neutrophil supernatants (LPS + S). Values are expressed as the means 6 SE; n = 3 (I, J); n = 10–13 alveoli from 3 mice (A2C9, E9,F9, H). Scale bars: 5 mm (D); 30 mm (A–C. E–G). N.S., no significant difference. **P , 0.01 compared with the control group, ##P , 0.01 compared with LPS group at 1 h.
Anti Mouse, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/CD5+Antibody%2C+anti-mouse/pmc12501240__41467_2025_63930_MOESM2_ESM-21-2-41
Average 93 stars, based on 1 article reviews
anti mouse - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

91
Bio-Rad feline cd5
Results recorded in Birman cats and in cats from other breeds.
Feline Cd5, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/Mouse+anti+CAT+CD5/pmc07111858-103-74-82
Average 91 stars, based on 1 article reviews
feline cd5 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

92
Miltenyi Biotec macs cell purification
Results recorded in Birman cats and in cats from other breeds.
Macs Cell Purification, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/CD5+(Ly-1)+MicroBeads%2C+mouse/pmc06355498__2018__195628__GAIGNAGE_SUPPL-22-1-16
Average 92 stars, based on 1 article reviews
macs cell purification - by Bioz Stars, 2026-09
92/100 stars
  Buy from Supplier

93
Bio-Rad unlabeled mouse anti cd5 mab
Results recorded in Birman cats and in cats from other breeds.
Unlabeled Mouse Anti Cd5 Mab, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/Mouse+anti+Rat+CD5/pmc02695032-61-10-21
Average 93 stars, based on 1 article reviews
unlabeled mouse anti cd5 mab - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

93
Cell Signaling Technology Inc rabbit anti cd5
Results recorded in Birman cats and in cats from other breeds.
Rabbit Anti Cd5, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/CD5+XP+Rabbit+mAb/pmc10073407-136-39-47
Average 93 stars, based on 1 article reviews
rabbit anti cd5 - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

94
Bio-Rad antiequine cd5 antibody
Results recorded in Birman cats and in cats from other breeds.
Antiequine Cd5 Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/Mouse+anti+Horse+CD5/pm27524460-68-26-34
Average 94 stars, based on 1 article reviews
antiequine cd5 antibody - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

91
R&D Systems anti mouse cd5 monoclonal antibody
Results recorded in Birman cats and in cats from other breeds.
Anti Mouse Cd5 Monoclonal Antibody, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cd5/Mouse+CD5+Antibody/pm35086743-90-24-35
Average 91 stars, based on 1 article reviews
anti mouse cd5 monoclonal antibody - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

Image Search Results


Journal: Cell

Article Title: Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

doi: 10.1016/j.cell.2021.12.018

Figure Lengend Snippet:

Article Snippet: Anti-Human CD5 (REA782) PE , Miltenyi Biotec , 130-110-990; RRID: AB_2658593.

Techniques: Purification, Recombinant, Staining, cDNA Synthesis, Gene Expression, Software, Microscopy

Figure 2. Dynamic alterations of lung TJ and AJ, HUVEC permeability, and neutrophils after LPS administration in vivo and in vitro. E-cadherin (A, A9), VE-cadherin (B, B9), occludin (C, C0), CD11b (E, E9), and MPO (F, F9) staining and quantification of relative intensity or positive cells in 1 alveoli at 1, 3, 5, and 7 d after administration of LPS (15 mg/kg) or saline; and CD3, CD5, CD19, and CD45 staining (G) at 3 d after LPS treatment are shown. D) Double-labeling images are shown of occludin (red) with E-cadherin or VE-cadherin (green) and superimposition with DAPI (blue). H) Percentage of CD11b-, MPO-, CD3-, CD5-, CD19-, and CD45-positive cells in 1 alveoli. I) Levels of IL-6, IL-8, and TNF-a and MPO activity in the supernatants of human neutrophils at 1, 3, 5, 7, and 9 h after LPS (10 mg/ml) treatment are shown. J) HUVEC monolayer permeability, as reflected by FITC-albumin fluorescence intensity, was analyzed at 1, 3, 5, 7, and 9 h after treatment of LPS alone or LPS + neutrophil supernatants (LPS + S). Values are expressed as the means 6 SE; n = 3 (I, J); n = 10–13 alveoli from 3 mice (A2C9, E9,F9, H). Scale bars: 5 mm (D); 30 mm (A–C. E–G). N.S., no significant difference. **P , 0.01 compared with the control group, ##P , 0.01 compared with LPS group at 1 h.

Journal: The FASEB Journal

Article Title: A self‐organized actomyosin drives multiple intercellular junction disruption and directly promotes neutrophil recruitment in lipopolysaccharide‐induced acute lung injury

doi: 10.1096/fj.201701506rr

Figure Lengend Snippet: Figure 2. Dynamic alterations of lung TJ and AJ, HUVEC permeability, and neutrophils after LPS administration in vivo and in vitro. E-cadherin (A, A9), VE-cadherin (B, B9), occludin (C, C0), CD11b (E, E9), and MPO (F, F9) staining and quantification of relative intensity or positive cells in 1 alveoli at 1, 3, 5, and 7 d after administration of LPS (15 mg/kg) or saline; and CD3, CD5, CD19, and CD45 staining (G) at 3 d after LPS treatment are shown. D) Double-labeling images are shown of occludin (red) with E-cadherin or VE-cadherin (green) and superimposition with DAPI (blue). H) Percentage of CD11b-, MPO-, CD3-, CD5-, CD19-, and CD45-positive cells in 1 alveoli. I) Levels of IL-6, IL-8, and TNF-a and MPO activity in the supernatants of human neutrophils at 1, 3, 5, 7, and 9 h after LPS (10 mg/ml) treatment are shown. J) HUVEC monolayer permeability, as reflected by FITC-albumin fluorescence intensity, was analyzed at 1, 3, 5, 7, and 9 h after treatment of LPS alone or LPS + neutrophil supernatants (LPS + S). Values are expressed as the means 6 SE; n = 3 (I, J); n = 10–13 alveoli from 3 mice (A2C9, E9,F9, H). Scale bars: 5 mm (D); 30 mm (A–C. E–G). N.S., no significant difference. **P , 0.01 compared with the control group, ##P , 0.01 compared with LPS group at 1 h.

Article Snippet: CD3, CD5, and CD45 antibodies were purchased from Proteintech Group (Rosemont, IL, USA).

Techniques: Permeability, In Vivo, In Vitro, Staining, Saline, Labeling, Activity Assay, Control

Results recorded in Birman cats and in cats from other breeds.

Journal: Research in Veterinary Science

Article Title: Relationship between rate of infection and markers of inflammation/immunity in Holy Birman cats with feline coronavirus

doi: 10.1016/j.rvsc.2014.08.009

Figure Lengend Snippet: Results recorded in Birman cats and in cats from other breeds.

Article Snippet: Immunophenotyping by flow cytometry was performed on aliquots of 50 μL of the cell suspension to identify lymphocyte subpopulations as previously described ( ) using the following panel of antibodies for feline surface antigen: 2.5 μL of mouse anti feline CD4 (specific for T helper cells, clone MCA1350, Serotec, Oxford, UK), 1 μL of mouse anti feline CD8 alpha/beta (specific for T cytotoxic cells, clone MCA1347G, Serotec, Oxford, UK), 50 μL of mouse anti feline CD5 (specific for T cells, clone MCA2038S, Serotec, Oxford, UK), and 1 μL of mouse anti canine CD21, specific for B cells, that cross reacts with feline species (clone MCA1781R, Serotec).

Techniques: